Literature DB >> 35465342

A novel compound heterozygous mutation in PYGM gene associated with McArdle's disease.

Salvatore Iacono1, Antonino Lupica1, Vincenzo Di Stefano1, Eugenia Borgione2, Filippo Brighina1.   

Abstract

McArdle's disease is an autosomal recessive glycogenosis due to mutation in the myophosphorylase gene (PYGM) resulting in a pure myopathy. The clinical onset typically occurs in childhood with cramps, myalgia, and intolerance to physical exercise, although late onset forms are also reported. We describe a case of a 17-year-old male complaining of cramps and myalgia following brief and intense exercise. The patient reported marked improvement in muscle fatigability few minutes after starting aerobic exercise. When he was a child, he had experienced few episodes of vomiting, nausea, and black colored urine following physical activity. Laboratory testings revealed high creatine kinase serum levels. Genetic testings for metabolic myopathies demonstrated a compound heterozygous for two PYGM mutations (p.R570Q and p.K754Nfs*49) allowing the diagnosis of McArdle's disease. To date, 183 mutations in the PYGM gene are listed in Human Gene Mutation Database Professional 2021.2, but this novel compound heterozygosis has never been reported before. ©2022 Gaetano Conte Academy - Mediterranean Society of Myology.

Entities:  

Keywords:  McArdle’s disease; PYGM; glycogenosis; hyperCKemia; second wind phenomenon

Mesh:

Substances:

Year:  2022        PMID: 35465342      PMCID: PMC9004334          DOI: 10.36185/2532-1900-067

Source DB:  PubMed          Journal:  Acta Myol        ISSN: 1128-2460


  10 in total

1.  McArdle disease: a clinical review.

Authors:  R Quinlivan; J Buckley; M James; A Twist; S Ball; M Duno; J Vissing; C Bruno; D Cassandrini; M Roberts; J Winer; M Rose; C Sewry
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-09-22       Impact factor: 10.154

2.  Molecular characterization of myophosphorylase deficiency (McArdle disease) in 34 patients from Southern France: identification of 10 new mutations. Absence of genotype-phenotype correlation.

Authors:  Robert Aquaron; Jean-Louis Bergé-Lefranc; Jean-Francois Pellissier; Marie-France Montfort; Michèle Mayan; Dominique Figarella-Branger; Michelle Coquet; Georges Serratrice; Jean Pouget
Journal:  Neuromuscul Disord       Date:  2007-02-26       Impact factor: 4.296

3.  Molecular heterogeneity of myophosphorylase deficiency (McArdle's disease): a genotype-phenotype correlation study.

Authors:  M A Martín; J C Rubio; J Buchbinder; R Fernández-Hojas; P del Hoyo; S Teijeira; J Gámez; C Navarro; J M Fernández; A Cabello; Y Campos; C Cervera; J M Culebras; A L Andreu; R Fletterick; J Arenas
Journal:  Ann Neurol       Date:  2001-11       Impact factor: 10.422

Review 4.  McArdle Disease: Update of Reported Mutations and Polymorphisms in the PYGM Gene.

Authors:  Gisela Nogales-Gadea; Astrid Brull; Alfredo Santalla; Antoni L Andreu; Joaquin Arenas; Miguel A Martín; Alejandro Lucia; Noemi de Luna; Tomàs Pinós
Journal:  Hum Mutat       Date:  2015-06-03       Impact factor: 4.878

5.  Spontaneous "second wind" and glucose-induced second "second wind" in McArdle disease: oxidative mechanisms.

Authors:  Ronald G Haller; John Vissing
Journal:  Arch Neurol       Date:  2002-09

6.  Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease.

Authors:  John Vissing; Morten Duno; Marianne Schwartz; Ronald G Haller
Journal:  Brain       Date:  2009-05-11       Impact factor: 13.501

Review 7.  McArdle disease: what do neurologists need to know?

Authors:  Alejandro Lucia; Gisela Nogales-Gadea; Margarita Pérez; Miguel A Martín; Antoni L Andreu; Joaquín Arenas
Journal:  Nat Clin Pract Neurol       Date:  2008-10

8.  Genotypic and phenotypic features of all Spanish patients with McArdle disease: a 2016 update.

Authors:  Alfredo Santalla; Gisela Nogales-Gadea; Alberto Blázquez Encinar; Irene Vieitez; Adrian González-Quintana; Pablo Serrano-Lorenzo; Inés García Consuegra; Sara Asensio; Alfonsina Ballester-Lopez; Guillem Pintos-Morell; Jaume Coll-Cantí; Helios Pareja-Galeano; Jorge Díez-Bermejo; Margarita Pérez; Antoni L Andreu; Tomàs Pinós; Joaquín Arenas; Miguel A Martín; Alejandro Lucia
Journal:  BMC Genomics       Date:  2017-11-14       Impact factor: 3.969

Review 9.  McArdle Disease: New Insights into Its Underlying Molecular Mechanisms.

Authors:  Francisco Llavero; Alazne Arrazola Sastre; Miriam Luque Montoro; Patricia Gálvez; Hadriano M Lacerda; Luis A Parada; José Luis Zugaza
Journal:  Int J Mol Sci       Date:  2019-11-25       Impact factor: 5.923

Review 10.  Inherited Neuromuscular Disorders: Which Role for Serum Biomarkers?

Authors:  Antonino Lupica; Vincenzo Di Stefano; Andrea Gagliardo; Salvatore Iacono; Antonia Pignolo; Salvatore Ferlisi; Angelo Torrente; Sonia Pagano; Massimo Gangitano; Filippo Brighina
Journal:  Brain Sci       Date:  2021-03-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.